Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Talley

Showing results (341-350 of 1,006) with videos related to

Pageof 101
Sort By:
Gut|October 30, 2007
Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trialsN J Talley, J Tack, T Ptak, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infectionN J Talley, D S Riff, H Schwartz, et al.
Chemosphere|October 31, 2020
Gut microbes modulate bioaccessibility of lead in soilShiv Bolan, Balaji Seshadri, Ian Grainge, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?H H Xia, J S Kalantar, H M Mitchell, et al.
BMJ (Clinical Research Ed.)|March 26, 1999
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study GroupN J Talley, J Janssens, K Lauritsen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 1, 1995
Bowel disorders impair functional status and quality of life in the elderly: a population-based studyE A O'Keefe, N J Talley, A R Zinsmeister, et al.
The American Journal of Gastroenterology|June 1, 1996
Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysisC T Loy, L M Irwig, P H Katelaris, et al.
Diseases of the Colon and Rectum|September 18, 1997
Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trialN A Talley, F Chen, D King, et al.
Digestive Diseases and Sciences|October 23, 1997
Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causesH X Xia, N J Talley, C T Keane, et al.
Diseases of the Colon and Rectum|March 4, 2000
Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence QuestionnaireW T Reilly, N J Talley, J H Pemberton, et al.
Pageof 101

Showing results (341-350 of 1,006) with videos related to

Sort By:
Pageof 101
Gut|October 30, 2007
Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trialsN J Talley, J Tack, T Ptak, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infectionN J Talley, D S Riff, H Schwartz, et al.
Chemosphere|October 31, 2020
Gut microbes modulate bioaccessibility of lead in soilShiv Bolan, Balaji Seshadri, Ian Grainge, et al.
Alimentary Pharmacology & Therapeutics|May 3, 2000
Can helicobacter pylori serology still be applied as a surrogate marker to identify peptic ulcer disease in dyspepsia?H H Xia, J S Kalantar, H M Mitchell, et al.
BMJ (Clinical Research Ed.)|March 26, 1999
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study GroupN J Talley, J Janssens, K Lauritsen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 1, 1995
Bowel disorders impair functional status and quality of life in the elderly: a population-based studyE A O'Keefe, N J Talley, A R Zinsmeister, et al.
The American Journal of Gastroenterology|June 1, 1996
Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysisC T Loy, L M Irwig, P H Katelaris, et al.
Diseases of the Colon and Rectum|September 18, 1997
Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trialN A Talley, F Chen, D King, et al.
Digestive Diseases and Sciences|October 23, 1997
Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causesH X Xia, N J Talley, C T Keane, et al.
Diseases of the Colon and Rectum|March 4, 2000
Validation of a questionnaire to assess fecal incontinence and associated risk factors: Fecal Incontinence QuestionnaireW T Reilly, N J Talley, J H Pemberton, et al.
Pageof 101